CRIS Current Research Information System

FESTI, DAVIDE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 14.263
AS - Asia 12.106
EU - Europa 8.807
AF - Africa 805
SA - Sud America 633
OC - Oceania 19
Continente sconosciuto - Info sul continente non disponibili 3
Totale 36.636
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 14.123
SG - Singapore 3.389
VN - Vietnam 3.368
CN - Cina 2.932
GB - Regno Unito 2.197
IT - Italia 1.487
DE - Germania 1.166
SE - Svezia 1.031
HK - Hong Kong 701
IN - India 634
FR - Francia 592
RU - Federazione Russa 475
BR - Brasile 424
UA - Ucraina 401
IE - Irlanda 376
ZA - Sudafrica 240
NL - Olanda 239
JP - Giappone 221
CI - Costa d'Avorio 187
KR - Corea 180
EE - Estonia 164
CH - Svizzera 141
FI - Finlandia 141
SC - Seychelles 119
TG - Togo 112
BG - Bulgaria 93
JO - Giordania 86
PH - Filippine 86
CA - Canada 79
AR - Argentina 76
BD - Bangladesh 72
NG - Nigeria 71
TH - Thailandia 71
PL - Polonia 57
ID - Indonesia 54
TR - Turchia 54
PK - Pakistan 49
EC - Ecuador 42
BE - Belgio 39
MX - Messico 39
TW - Taiwan 39
ES - Italia 37
IQ - Iraq 37
AT - Austria 36
GR - Grecia 36
IR - Iran 24
LT - Lituania 23
CL - Cile 21
EG - Egitto 21
SA - Arabia Saudita 20
AU - Australia 17
VE - Venezuela 17
LB - Libano 15
CO - Colombia 14
PY - Paraguay 14
CZ - Repubblica Ceca 12
ET - Etiopia 12
HR - Croazia 12
MY - Malesia 12
PE - Perù 12
PT - Portogallo 12
UZ - Uzbekistan 12
KE - Kenya 10
AL - Albania 9
BO - Bolivia 9
TN - Tunisia 9
RO - Romania 7
AZ - Azerbaigian 6
IL - Israele 5
KZ - Kazakistan 5
MA - Marocco 5
NP - Nepal 5
AE - Emirati Arabi Uniti 4
AO - Angola 4
BA - Bosnia-Erzegovina 4
HN - Honduras 4
RS - Serbia 4
SI - Slovenia 4
UY - Uruguay 4
CR - Costa Rica 3
DK - Danimarca 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
KG - Kirghizistan 3
NI - Nicaragua 3
OM - Oman 3
SN - Senegal 3
SY - Repubblica araba siriana 3
HU - Ungheria 2
JM - Giamaica 2
KW - Kuwait 2
LA - Repubblica Popolare Democratica del Laos 2
LV - Lettonia 2
MD - Moldavia 2
NZ - Nuova Zelanda 2
PS - Palestinian Territory 2
TL - Timor Orientale 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BB - Barbados 1
BH - Bahrain 1
Totale 36.609
Salva come PNG Salva come JPEG
Città #
Singapore 2.325
Southend 1.966
Fairfield 1.763
Ashburn 1.433
Chandler 1.064
Ho Chi Minh City 691
Hong Kong 650
Hanoi 638
San Jose 617
Santa Clara 613
Woodbridge 604
Seattle 590
Houston 560
Wilmington 540
Princeton 474
Cambridge 452
Dong Ket 398
Beijing 389
Dublin 375
Ann Arbor 366
Hefei 340
Boardman 308
Bologna 288
Jacksonville 231
Lauterbourg 231
New York 216
Nanjing 207
Los Angeles 200
Westminster 192
Abidjan 187
Tokyo 187
Padova 156
Dallas 137
Seoul 134
Berlin 128
Milan 126
Da Nang 120
Haiphong 114
Lomé 112
Council Bluffs 111
Bern 110
Buffalo 110
Frankfurt am Main 107
Medford 102
Saint Petersburg 102
San Diego 97
Helsinki 95
Sofia 89
Amman 86
Jinan 86
Shenyang 76
Redondo Beach 75
Changsha 74
Munich 73
Turin 70
Abeokuta 69
Dearborn 67
Bremen 65
São Paulo 65
Guangzhou 63
Shanghai 63
Las Vegas 59
Rome 59
Tianjin 58
Hebei 57
Des Moines 56
Nanchang 56
Florence 51
Johannesburg 51
Redwood City 46
Jiaxing 44
Orem 42
Mahé 41
Biên Hòa 40
The Dalles 39
Yubileyny 38
Bangkok 36
Bengaluru 36
Mülheim 36
North Charleston 36
Turku 36
Brussels 35
Zhengzhou 35
Hangzhou 33
Hải Dương 32
Falkenstein 31
Pune 31
Redmond 31
Toronto 30
Norwalk 29
Phoenix 29
Xi'an 29
Can Tho 28
Chicago 28
London 28
Wuhan 28
Amsterdam 26
Hyderabad 26
Warsaw 26
Washington 26
Totale 23.455
Salva come PNG Salva come JPEG
Nome #
Adding Liver Stiffness Measurement to the Routine Evaluation of Hepatocellular Carcinoma Resectability Can Optimize Clinical Outcome 301
Accuracy of spleen stiffness measurement for the diagnosis of clinically significant portal hypertension in patients with compensated advanced chronic liver disease: a systematic review and individual patient data meta-analysis 287
Differences in liver stiffness values obtained with new ultrasound elastography machines and Fibroscan: A comparative study 283
Laser ablation is superior to TACE in large-sized hepatocellular carcinoma: A pilot case-control study 280
A statistical model predicting high hepatocyte proliferation index and the risk of developing hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis 275
Ablation for hepatocellular carcinoma: beyond the standard indications 265
The importance of HCV on the burden of chronic liver disease in Italy: A multicenter prevalence study of 9,997 cases 257
How to clarify the Baveno VI criteria for ruling out varices needing treatment by noninvasive tests 256
A combined Baveno VII and spleen stiffness algorithm to improve the non-invasive diagnosis of clinically significant portal hypertension in patients with compensated advanced chronic liver disease 247
Clinical trial: modulation of human placental multidrug resistance proteins in cholestasis of pregnancy by ursodeoxycholic acid. 246
Clinical application of faecal calprotectin in ulcerative colitis patients 246
G-CSF administration is not related to Peg-IFN alfa-2b treatment duration nor response in liver transplanted patients with HCV recurrence. 243
A nomogram-based prognostic model for advanced hepatocellular carcinoma patients treated with sorafenib: A multicenter study 239
A RETROSPECTIVE STUDY ON INTRAHEPATIC CHOLESTASIS OF PREGNANCY: MARKERS OF PREMATURE DELIVERY 235
Assessment of liver stiffness measurement and ultrasound findings change during inotuzumab ozogamicin cycles for relapsed or refractory acute lymphoblastic leukemia 225
The aetiology of chronic hepatitis in Italy: Results from a multicentre national study 224
Comparison of prognostic models in advanced hepatocellular carcinoma patients undergoing Sorafenib: A multicenter study 220
Clinical impact of sarcopenia assessment in patients with hepatocellular carcinoma undergoing treatments 219
Correlazione materno-fetale degli acidi biliari in corso di colestasi gravidica 218
DAAs treatment in HCV recurrence after liver transplantation: Clinical usefulness of non-invasive methods 216
Eicosapentaenoic Acid Reduces Fecal Levels of Calprotectin and Prevents Relapse in Patients With Ulcerative Colitis 215
Relationship between indocyanine green retention test, decompensation and survival in patients with Child-Pugh A cirrhosis and portal hypertension 214
Hepatocellular carcinoma risk assessment by the measurement of liver stiffness variations in HCV cirrhotics treated with direct acting antivirals 213
Clinical efficacy and effectiveness of ursodeoxycholic acid in cholestatic liver diseases. 212
Adverse Food Reaction and Functional Gastrointestinal Disorders: Role of the Dietetic Approach 209
Clinical impact of sarcopenia assessment in patients with liver cirrhosis 208
Pancreatic ultrasound elastography and its clinical use in predicting the risk of pancreatic fistulas after pancreatic resection 208
Indocyanine green as a predictor of clinically significant portal hypertension in a prospective cohort study of patients with chronic liver disease 207
Size and location of spontaneous portosystemic shunts predict the risk of decompensation in cirrhotic patients 205
Benign hepatic nodular lesions after treatment for childhood cancer 202
Chronic hepatitis B in Italy: New features of an old disease - Approaching the universal prevalence of hepatitis B e antigen-negative cases and the eradication of hepatitis D infection 200
Measurement of spleen stiffness to evaluate portal hypertension and the presence of esophageal varices in patients with HCV-related cirrhosis 197
Gut microbiota, metabolome and immune signatures in patients with uncomplicated diverticular disease 197
Interferon plus ribavirin and interferon alone in preventing hepatocellular carcinoma: a prospective study on patients with HCV related cirrhosis. 197
Sulfasalazine in Prevention of Pouchitis After Proctocolectomy with Ileal Pouch–Anal Anastomosis for Ulcerative Colitis 196
H 2breath testing for other gas-related syndromes 193
Corrigendum to “Differences in liver stiffness values obtained with new ultrasound elastography machines and fibroscan: A comparative study” [Dig. Liver Dis. 49 (2017) 802–808](S1590865817302463)(10.1016/j.dld.2017.03.001) 192
Sarcopenia predicts ascitic decompensation and mortality independently of portal hypertension status in patients with advanced chronic liver disease outside the liver transplantation setting 191
Gut Microbiota and Celiac Disease 188
A SPLEEN STIFFNESS MEASUREMENT-BASED MODEL FOR THE RECOGNITION OF HIGH RISK VARICES: BAVENO VI CRITERIA AND BEYOND 188
DAAs treatment in hepatitis C virus recurrence after Liver Transplantation: clinical usefulness of non-invasive methods 187
Effect of a symbiotic preparation on the clinical manifestations of irritable bowel syndrome, constipation-variant: Results of an open, uncontrolled multicenter study 187
“Are the Expanded Baveno VI Criteria really safe to screen compensated cirrhotic patients for high-risk varices?” 186
Body weight,lifestyle,dietary habits and gastroesophageal reflux disease 186
Plasma antioxidant enzymes and clastogenic factors as possible biomarkers of colorectal cancer risk 182
HCV infection is a risk factor for gallstone disease in liver cirrhosis: An Italian epidemiological survey 182
DIAGNOSTIC ACCURACY OF LIVER AND SPLEEN STIFFNESS MEASUREMENT FOR PORTAL HYPERTENSION USING BIDIMENSIONAL SHEAR WEAVE ELASTOGRAPHY 181
The non‐invasive evaluation of liver involvement in patients with cystic fibrosis: A prospective study 180
Liver stiffness and serum fibrosis biomarker variations after DAAs treatment: Predictive role in HCC development in cirrhotic patients 180
"Alimentazione e salute: Strategie nutrizionali per la prevenzione delle malattie”. 19 gennaio 2006 - Oratorio San Filippo Neri – Via Manzoni, 5 - Bologna. 179
Dieta e microbiota intestinale: Due facce di una stessa medaglia? 179
null 179
Silybin and the liver: from basic research to clinical practice 178
Are noninvasive methods clinically useful in advanced, decompensated liver cirrhosis when "les Jeux Sont Faits"? 178
Indocyanine green as a predictor of clinically significant portal hypertension in a prospective cohort study of patients with chronic liver disease. 177
HIGH FREE AND GLYCOCONJUGATED AND LOW TAUROCONJUGATED BA LEVELS IN SERUM ARE THE MIRROR OF INTESTINAL EVENTS AND HEPATIC UPTAKE 176
Mathematical model predicting high hepatocyte proliferation index and risk of HCC in patients with HCV related cirrhosis: a proposal for clinical validation 173
Spleen stiffness measurement: A useful prognostic tool in HCV patients treated with DAAs regimens 172
A spleen stiffness measurement-based model for the recognition of high risk varices: Baveno VI criteria and beyond 172
Spleen stiffness decrease as mirror of portal hypertension changes after successful interferon-free therapy in chronic-HCV patients 172
Interleukin 28 polymorphisms and hepatocellular carcinoma development after direct acting antiviral therapy for chronihepatitis c 172
Ductal stones recurrence after extracorporeal shock wave lithotripsy for difficult common bile duct stones: Predictive factors 171
THU-492 - Liver stiffness and serum fibrosis biomarker variations after DAAs treatment: predictive role in hepatocellular carcinoma development in in cirrhotic patients 170
Pharmacological modulation of MRP2 in primary biliary cirrhosis 169
Simultaneous Analysis of SEPT9 Promoter Methylation Status, Micronuclei Frequency, and Folate-Related Gene Polymorphisms: The Potential for a Novel Blood-Based Colorectal Cancer Biomarker 168
Efficacy of ursodeoxycholic acid administration on clinical manifestations of gallstones and gastrointestinal motility 167
Spleen stiffness mirrors changes in portal hypertension after successful interferon-free therapy in chronic-hepatitis C virus patients 167
Nerve fiber overgrowth in patients with symptomatic diverticular disease 167
Helicobacter pylori infection causes persistent platelet activation in vivo through enhanced lipid peroxidation. 166
Alimentazione e salute: Linee guida per il Consumatore Bolognese, 29 aprile 2004. Oratorio S.Filippo Neri, Via Manzoni, 5 - Bologna 166
Role of imaging techniques in liver veno-occlusive disease diagnosis: recent advances and literature review 166
Non-invasive tests for the prediction of post-hepatectomy liver failure in the elderly 165
Focal nodular hyperplasia of the liver in children after hematopoietic stem cell transplantation. 164
Spleen stiffness measurement can predict clinical complications in compensated HCV-related cirrhosis: a prospective study 163
Proton pump inhibitors in cirrhosis: tradition or evidence based practice? 163
Comparison of prognostic models in predicting survival of patients with advanced hepatocellular carcinoma undergoing sorafenib treatment: a multicenter cohort study 163
Treatment of nonalcoholic fatty liver with focus on emerging drugs 162
Regolazione dei trasportatori placentari degli acidi biliari MRP2, MRP3, MRP4 da parte dell’acido ursodesossicolico in corso di colestasi gravidica 162
Usefulness of liver stiffness measurement in predicting hepatic veno-occlusive disease development in patients who undergo HSCT 162
THU-490 - Spleen stiffness measurement: a useful prognostic tool in HCV patients treated with DAAs regimens 162
The foetal-maternal circulation of bile acids and bilirubin: effects of cholestasis and UDCA administration. 162
A novel spleen-dedicated stiffness measurement by FibroScan® improves the screening of high-risk oesophageal varices 162
Dietary Management in IBS Patients 161
Curcumin and fennel essential oil improve symptoms and quality of life in patients with irritable bowel syndrome 161
Focal nodular hyperplasia of the liver after intensive treatment for pediatric cancer: is hematopoietic stem cell transplantation a risk factor? 160
Value of Transient Elastography Measured With Fibroscan in Predicting the Outcome of Hepatic Resection for Hepatocellular Carcinoma. 160
Non-invasive diagnostic approach to non-alcoholic fatty liver disease: Current evidence and future perspectives 160
A new point-of-care portable immunosensor for non-invasive assessment of oro-ileal transit time by oral fluid tauroursodeoxycholate measurement after its oral load. 158
Incidence of gallstone disease in Italy: Results from a multicenter, population-based Italian study (the MICOL project). 158
Indocyanine Green 15-min Retention test (ICG-r15) as a predictor of clinical decompensation in patients with compensated liver cirrhosis. 158
Biliary symptoms, gallbladder motility, and cholecystectomy 157
Pathophysiology and Therapeutic Strategies for Symptomatic Uncomplicated Diverticular Disease of the Colon 156
Mathematical model predicting high hepatocyte proliferation index and risk of HCC in patients with HCV related cirrhosis: a proposal for clinical validation 156
Indocyanine green clearance (ICG) as a predictor of 2-years clinical decompensation and mortality in patients with compensated liver cirrhosis 156
Indocyanine green clearance as a marker of decompensation and clinically significant portal hypertension in patients with liver cirrhosis. 156
Spleen Stiffness Measurements Predict the Risk of Hepatic Decompensation after Direct-Acting Antivirals in HCV Cirrhotic Patients 156
Indocyanine green clearance (ICG) as a predictor of clinical decompensation and mortality in patients with compensated liver cirrhosis. 155
Autoimmune liver diseases in a paediatric population with coeliac disease. A 10-year single-centre experience 154
Micronucleus frequency in human peripheral blood lymphocytes as a biomarker for the early detection of colorectal cancer risk. 154
Non-invasive panel tests for gastrointestinal motility monitoring within the MARS-500 Project. 154
Totale 19.069
Salva come PNG Salva come JPEG
Categoria #
all - tutte 100.846
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 100.846
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.199 0 0 0 0 0 0 0 0 0 161 122 916
2021/20224.816 343 172 246 271 402 218 113 251 170 247 1.674 709
2022/20234.485 484 603 254 568 314 358 124 234 830 104 349 263
2023/20241.445 70 231 109 151 109 391 71 71 70 76 49 47
2024/20255.127 206 864 503 330 913 246 381 136 63 380 218 887
2025/202611.372 988 1.084 1.156 788 1.277 703 1.488 373 2.666 849 0 0
Totale 37.304